The non-benzodiazepine anxiolytic etifoxine limits mechanical allodynia and anxiety-like symptoms in a mouse model of streptozotocin-induced diabetic neuropathy.
More than 450 million people worldwide suffer from diabetes, or 1 in 11 people. Chronic hyperglycemia degrades patients' quality of life and the development of neuropathic pain contributes to the burden of this disease. In this study, we used the mouse model of streptozocin-induced diabetic typ...
Guardado en:
Autores principales: | Géraldine Gazzo, Marlene Salgado Ferrer, Pierrick Poisbeau |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b600b610af8d4133a6f1ddeb47c164d9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An update on the anxiolytic and neuroprotective properties of etifoxine: from brain GABA modulation to a whole-body mode of action
por: Nuss P, et al.
Publicado: (2019) -
Cognitive Behavioral Therapy Reduces Benzodiazepine Anxiolytics Use in Japanese Patients with Mood and Anxiety Disorders: A Retrospective Observational Study
por: Nakajima A, et al.
Publicado: (2020) -
Loop diuretics have anxiolytic effects in rat models of conditioned anxiety.
por: Andrew D Krystal, et al.
Publicado: (2012) -
Prevalence and characteristics of cutaneous allodynia in probable migraine
por: Seung Min Han, et al.
Publicado: (2021) -
ANXIOLYTIC EFFECT OF HERBAL REMEDY «NOOPHYT»
por: Ya. G. Razuvaeva, et al.
Publicado: (2012)